Exploratory Comparison of the ELISA, MSD and NULISA Technologies

Presented at the European Bioanalysis Forum (EBF), this poster explores the development of a generic pharmacokinetic (PK) assay designed to quantify multiple monoclonal antibodies in animal matrices without requiring assay redevelopment for each candidate. The study compares three analytical platforms: NULISA ARGO HT, MSD QuickPlex SQ 120, and ELISA using the Tecan Spark 20M. Results demonstrate the feasibility of generic PK assay development using NULISA ARGO HT and compare platform performance in terms of dynamic range, sensitivity, and sample dilution requirements. The findings highlight key considerations, including the hook effect, assay diluent composition, and context of use (CoU), to help guide platform selection based on study requirements.

KCAS Bio Authors: Cendrine Josson, Julien Claret, Alain Poyau, and Christine Bain.

If you have any questions about this poster or want to learn more about our capabilities, please fill out the form below to speak with a scientist.